Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters

被引:0
|
作者
Giannakopoulos, Bill [1 ,2 ]
Krilis, Steven A. [1 ,3 ]
机构
[1] Univ New South Wales, Fac Med & Hlth, St George & Sutherland Campus,Level 2,Pitney Bldg,, Sydney, NSW 2217, Australia
[2] St George Publ Hosp, Dept Rheumatol, Kogarah, Sydney 2217, Australia
[3] St George Publ Hosp, Dept Infect Dis Immunol & Sexual Hlth, Kogarah, Sydney 2217, Australia
关键词
Beta 2 glycoprotein I; Domain; 5; Antiphospholipid syndrome; Ischemia-reperfusion injury; Thrombosis; BETA(2)-GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; GLYCOPROTEIN-I; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; LIPID-BINDING; INHIBITOR; RECEPTOR; PLASMIN; ANGIOGENESIS;
D O I
10.1016/j.clim.2024.110282
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Beta 2 glycoprotein I ((32GPI) is the major autoantigen in the antiphospholipid syndrome, an autoimmune disorder characterized by thrombotic and obstetric complications. The autoantibodies that target beta 2 glycoprotein I are pathogenic and contribute to disease pathogenesis. The (32GPI molecule is composed of 5 domains that are numbered 1 through to 5. Autoantibodies bind mainly to domain 1 whereas the majority of the biological functions of the (32GPI molecule in diverse processes such as apoptotic cell clearance, complement regulation, lipopolysaccharide clearance and anticoagulation have been localised to domain 5 and its unique biochemistry, reviewed in this article. The role of purified domain 5 peptide as a potential therapeutic agent in APS and ischemia reperfusion injury is discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Beta2-agonists: Friend or foe?
    Ford, JG
    Iqbal, J
    Sunmonu, Y
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 23 (04) : 369 - 375
  • [2] Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?
    Bidooki, Seyed Hesamoddin
    Navarro, Maria A.
    Fernandes, Susana C. M.
    Osada, Jesus
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (04) : 3134 - 3163
  • [3] Poster: Friend or Foe? Context Authentication for Trust Domain Separation in IoT Environments
    Miettinen, Markus
    Huang, Jialin
    Thien Duc Nguyen
    Asokan, N.
    Sadeghi, Ahmad-Reza
    PROCEEDINGS OF THE 9TH ACM CONFERENCE ON SECURITY & PRIVACY IN WIRELESS AND MOBILE NETWORKS (WISEC'16), 2016, : 225 - 226
  • [4] Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
    de Laat, Bas
    de Groot, Philip G.
    CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (01) : 70 - 76
  • [5] Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
    Bas de Laat
    Philip G. de Groot
    Current Rheumatology Reports, 2011, 13 : 70 - 76
  • [6] Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
    McDonnell, Thomas
    Artim-Esen, Bahar
    Wincup, Chris
    Ripoll, Vera M.
    Isenberg, David
    Giles, Ian P.
    Rahman, Anisur
    Pericleous, Charis
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [7] Identification of the domain of beta2-glycoprotein I involved in binding to LRP
    Van Lummel, M
    Derksen, RHWM
    Lutters, BCH
    Westein, E
    Lenting, PJ
    de Groot, PG
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 616 - 617
  • [8] PEGYLATED DOMAIN I OF BETA-2-GLYCOPROTEIN I PREVENTS THROMBOSIS IN A MOUSE MODEL
    McDonnell, Thomas C. R.
    Willis, Rohan
    Pericleous, Charis
    Giles, Ian
    Romay-Penabad, Zurina
    Papalardo, Elizabeth
    Ioannou, Yiannis
    Rahman, Anisur
    RHEUMATOLOGY, 2017, 56 : 145 - 145
  • [9] The Significance of Antibodies against Domain I of Beta-2 Glycoprotein I in Antiphospholipid Syndrome
    Kelchtermans, Hilde
    Chayoua, Walid
    de Laat, Bas
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (05): : 458 - 465
  • [10] Function of domain 5 of human β2 glycoprotein I:: Interaction with cardiolipin
    Hagihara, Y
    Yoshimura, T
    Gota, Y
    Kato, H
    RECENT PROGRESS IN BLOOD COAGULATION AND FIBRINOLYSIS, 1997, 1129 : 9 - 17